PAVmed Inc.
NCM: PAVMLive Quote
About PAVmed Inc.
Healthcare
Medical Devices
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York
📊 Fundamental Analysis
PAVmed Inc. demonstrates exceptional profitability, with a profit margin of 564.8%.
The company recently reported 420.0% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -32.3%, which indicates that capital utilization is currently under pressure.
At a current price of $9.24, PAVM currently trades near the bottom of its 52-week range (14%), indicating potential value or weakness (Range: $6.00 - $28.44).
🏥 Financial Health
✅
Profit Margin
Excellent
⚠️
Debt/Equity
Moderate
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$33.50M
Trailing P/E
--
Forward P/E
-0.54
Beta (5Y)
0.81
52W High
$28.44
52W Low
$6.00
Avg Volume
1.04M
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App